News

Abbvie (($ABBV)) announced an update on their ongoing clinical study. Study Overview: AbbVie is spearheading a Phase 2 ...
Researchers at the University of Chicago have developed a "universal" chimeric antigen receptor (CAR) platform that offers ...
University of Oklahoma researchers reveal details on amylin receptors, aiding the development of new obesity treatments.
Although G protein-coupled receptors (GPCRs) are crucial to the regulation of most functions in the human body, very little is known about how they work. In a new study, researchers at the Biozentrum ...
A new study by UB researchers has revealed that the absence of a single interaction within a brain receptor reduces its activity. The discovery advances understanding of how certain brain diseases ...
Activating cell-surface receptors: It takes a dimer to bind Date: October 29, 2015 Source: Okinawa Institute of Science and Technology Graduate University - OIST Summary: Based on meta-analysis of ...
Adhesion G protein-coupled receptors have a large extracellular region (shown in green and orange) that extends into space outside the cell. Almost 35% of drugs approved by the Food and Drug ...
A study reveals a new understanding of how amylin receptors react upon being activated, an advancement that could be crucial ...
Images of crucial cell receptors show promising new drug targets Date: December 17, 2024 Source: University of Chicago Summary: New research combines two powerful imaging techniques to study the ...
Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study ...